Tuesday, February 06, 2018 9:03:29 AM
GoooGreen, Inc. Announces Letter of Intent has Been Executed
POMPANO BEACH, Fla., Feb. 06, 2018 (GLOBE NEWSWIRE) -- GoooGreen, Inc., (OTCPK: GOOO) announced the company, with board approval, has signed a letter of intent, subject to finalization of due diligence, to acquire Visita Skin Care products. GoooGreen’s proposed new Visita division will begin operating a cosmetic and skin care entity with the intent of converting it into a wholly owned subsidiary under the GoooGreen umbrella. Closing is expected to be concluded within 120 days. The company is in the selection process of a production and fulfillment facility for Visita’s cosmetics and skin care product line.
Brief Description:
Visita developed and hold the formulation rights to a Skin Treatment Lotion and Cleanser for persons affected by skin conditions: psoriasis and atopic dermatitis, eczema and pruritus. The markets for psoriasis and atopic dermatitis are large. Atopic dermatitis is a type of eczema, an inflammatory pruritus, chronically relapsing, non-contagious skin disorder. Together these two diseases affect as much as 20% of the population. The company believes the Visita product line will enhance shareholder value. The company’s initial due diligence research indicates this product line is consumer desirable for the compounds imbedded in the products appear to have chemical properties that are: (1) effective, (2) have little or no side effects, (3) can be used on younger patients, (4) can be used for longer periods of time, and (5) are cost efficient.
The company will be updating shareholders with ongoing updates and details as appropriate. Further information about the Vista acquisition is expected to be announced over the next months.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM